Literature DB >> 29608143

Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression.

Heng Lin, Shuang Wei, Elaine M Hurt, Michael D Green, Lili Zhao, Linda Vatan, Wojciech Szeliga, Ronald Herbst, Paul W Harms, Leslie A Fecher, Pankaj Vats, Arul M Chinnaiyan, Christopher D Lao, Theodore S Lawrence, Max Wicha, Junzo Hamanishi, Masaki Mandai, Ilona Kryczek, Weiping Zou.   

Abstract

Entities:  

Year:  2018        PMID： 29608143      PMCID： PMC5873851          DOI： 10.1172/JCI120803

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  44 in total

Review 1.  Diversity, Mechanisms, and Significance of Macrophage Plasticity.

Authors:  Massimo Locati; Graziella Curtale; Alberto Mantovani
Journal:  Annu Rev Pathol       Date:  2019-09-17       Impact factor: 23.472

2.  MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment.

Authors:  Douglas D Fang; Qiuqiong Tang; Yanhui Kong; Qixin Wang; Jiaxing Gu; Xu Fang; Peng Zou; Tao Rong; Jingwen Wang; Dajun Yang; Yifan Zhai
Journal:  J Immunother Cancer       Date:  2019-11-28       Impact factor: 13.751

Review 3.  The role of macrophages in anti-tumor immune responses: pathological significance and potential as therapeutic targets.

Authors:  Hirotake Tsukamoto; Yoshihiro Komohara; Hiroyuki Oshiumi
Journal:  Hum Cell       Date:  2021-04-27       Impact factor: 4.174

Review 4.  Phenotypic plasticity of myeloid cells in glioblastoma development, progression, and therapeutics.

Authors:  Zengpanpan Ye; Xiaolin Ai; Linjie Zhao; Fan Fei; Ping Wang; Shengtao Zhou
Journal:  Oncogene       Date:  2021-09-23       Impact factor: 9.867

5.  The expanding constellation of immune checkpoints: a DNAMic control by CD155.

Authors:  Vincenzo Bronte
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

6.  The polymorphism rs975484 in the protein arginine methyltransferase 1 gene modulates expression of immune checkpoint genes in hepatocellular carcinoma.

Authors:  Michael Schonfeld; Jie Zhao; Amberly Komatz; Steven A Weinman; Irina Tikhanovich
Journal:  J Biol Chem       Date:  2020-04-03       Impact factor: 5.157

7.  Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity.

Authors:  Hui-Ming Chen; William van der Touw; Yuan Shuo Wang; Kyeongah Kang; Sunny Mai; Jilu Zhang; Dayanira Alsina-Beauchamp; James A Duty; Sathish Kumar Mungamuri; Bin Zhang; Thomas Moran; Richard Flavell; Stuart Aaronson; Hong-Ming Hu; Hisashi Arase; Suresh Ramanathan; Raja Flores; Ping-Ying Pan; Shu-Hsia Chen
Journal:  J Clin Invest       Date:  2018-10-22       Impact factor: 14.808

8.  Integrin αvβ8-expressing tumor cells evade host immunity by regulating TGF-β activation in immune cells.

Authors:  Naoki Takasaka; Robert I Seed; Anthony Cormier; Andrew J Bondesson; Jianlong Lou; Ahmed Elattma; Saburo Ito; Haruhiko Yanagisawa; Mitsuo Hashimoto; Royce Ma; Michelle D Levine; Jean Publicover; Rashaun Potts; Jillian M Jespersen; Melody G Campbell; Fraser Conrad; James D Marks; Yifan Cheng; Jody L Baron; Stephen L Nishimura
Journal:  JCI Insight       Date:  2018-10-18

9.  Identification of chemical compounds regulating PD-L1 by introducing HiBiT-tagged cells.

Authors:  Yutaro Uchida; Takahide Matsushima; Ryota Kurimoto; Tomoki Chiba; Yuki Inutani; Hiroshi Asahara
Journal:  FEBS Lett       Date:  2021-01-20       Impact factor: 4.124

10.  PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways.

Authors:  Yunlong Zhao; Calvin K Lee; Chia-Hao Lin; Rodrigo B Gassen; Xiaozheng Xu; Zhe Huang; Changchun Xiao; Cristina Bonorino; Li-Fan Lu; Jack D Bui; Enfu Hui
Journal:  Immunity       Date:  2019-11-19       Impact factor: 31.745
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.